CATALYST FLEX
LIVE

Serial Number

90606273

Owner

Catalyst Clinical Research LLC

Attorney

Philip J. Cardinale

First Use Date

Jan 31, 2021

Filing Date

Mar 26, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CATALYST FLEX Trademark

Serial Number: 90606273

CATALYST FLEX is a trademark filed by Catalyst Clinical Research LLC on March 26, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Catalyst Clinical Research LLC (7 trademarks)

Wilmington, NC 28409

Entity Type: 16

Trademark Details

Filing Date

March 26, 2021

Registration Date

Not Registered

First Use Anywhere

January 31, 2021

First Use in Commerce

January 31, 2021

Goods & Services

Downloadable electronic materials in the nature of pamphlets, articles and e-brochures in the fields of research and development of pharmaceuticals, medical devices and biotechnology

Printed Matter, namely, brochures, articles, instructional and teaching materials and reports in the fields of research and development of pharmaceutical, medical devices and biotechnology

Business consulting and information services in the field of commercializing of pharmaceuticals, medical devices, and biotechnology; medical consulting, namely, consulting services in the field of medical product approval for commercial purposes, providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; medical consulting, namely, consulting services in the field of medical product approval for commercial purposes, providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; clinical trial consulting, monitoring, and oversight, namely, business consulting in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes, business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; biostatistical consulting, namely, statistical analysis and reporting services for business purposes; database management in the pharmaceutical fields; providing independent review of clinical trials for business purposes

Clinical trial consulting, monitoring, and oversight, namely, conducting clinical trials for others, consulting services for others in the field of design, planning, and implementation project management of clinical trials

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 1, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 31, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 30, 2024 RCSC
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 28, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 28, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 28, 2024 REAP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 29, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 28, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 28, 2023 RCSC
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 20, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 20, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 20, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 20, 2023 REAP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 31, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 27, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 27, 2022 GNSL
SUSPENSION LETTER WRITTEN
Sep 27, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 22, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2022 CRFA
ASSIGNED TO LIE
Aug 22, 2022 ALIE
NOTICE OF REVIVAL - E-MAILED
Jul 28, 2022 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 27, 2022 TROA
PETITION TO REVIVE-GRANTED
Jul 27, 2022 PETG
TEAS PETITION TO REVIVE RECEIVED
Jul 27, 2022 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 27, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 27, 2022 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 5, 2021 GNRN
NON-FINAL ACTION E-MAILED
Nov 5, 2021 GNRT
NON-FINAL ACTION WRITTEN
Nov 5, 2021 CNRT
ASSIGNED TO EXAMINER
Nov 3, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 3, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 2, 2021 NWOS
NEW APPLICATION ENTERED
Mar 30, 2021 NWAP